Detalhe da pesquisa
1.
Risk of hospitalization and sequelae in patients with COVID-19 treated with 3-day early remdesivir vs. controls in the vaccine and Omicron era: A real-life cohort study.
J Med Virol
; 95(3): e28660, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905216
2.
Molnupiravir and Nirmatrelvir/Ritonavir: Tolerability, Safety, and Adherence in a Retrospective Cohort Study.
Viruses
; 15(2)2023 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851598
3.
Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern.
Elife
; 112022 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36413383